GO	[-15.83 -0.87]	[-0.87 -0.54]	[-0.54 -0.31]	[-0.31 -0.12]	[-0.12 0.00]	[0.00 0.13]	[0.13 0.32]	[0.32 0.58]	[0.58 0.79]	[0.79 1.57]	[1.57 26.66]
FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP	0.325	-1.593	-1.177	-1.177	-0.418	-0.606	-1.593	-2.132	-0.279	1.697	10.897
NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN	-0.381	-0.381	-1.501	-2.322	0.233	0.878	-1.501	-0.622	0.233	0.233	7.363
ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP	-0.764	-1.409	-0.764	-0.764	-0.407	3.196	0.427	-0.407	-0.764	0.216	2.565
SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP	-0.870	-0.378	-0.378	0.236	-0.870	-0.870	-0.870	-0.378	0.527	2.038	2.720
LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE	0.279	-0.787	-0.787	-0.787	0.279	-0.324	-0.787	-0.324	1.058	-0.324	3.850
HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_UP HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_UP	-0.351	0.992	-0.828	0.256	-0.828	-0.828	-0.351	-0.351	-0.351	0.256	3.665
